PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Saved in:
| Title: | PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial. |
|---|---|
| Authors: | Maggie Liu, Si-Yang1 (AUTHOR), Huang, Jie1,2 (AUTHOR), Deng, Jia-Yi1,2 (AUTHOR), Xu, Chong-Rui2 (AUTHOR), Yan, Hong-Hong2,3 (AUTHOR), Yang, Ming-Yi2 (AUTHOR), Li, Yang-Si2 (AUTHOR), Ke, E-E2 (AUTHOR), Zheng, Ming-Ying2 (AUTHOR), Wang, Zhen2 (AUTHOR), Lin, Jia-Xin2 (AUTHOR), Gan, Bin2 (AUTHOR), Zhang, Xu-Chao2 (AUTHOR), Chen, Hua-Jun2 (AUTHOR), Wang, Bin-Chao2 (AUTHOR), Tu, Hai-Yan2 (AUTHOR), Yang, Jin-Ji2 (AUTHOR), Zhong, Wen-Zhao2 (AUTHOR), Li, Yangqiu1,4 (AUTHOR) yangqiuli@hotmail.com, Zhou, Qing1,2,3 (AUTHOR) gzzhouqing@126.com |
| Source: | Science Bulletin. Feb2024, Vol. 69 Issue 4, p535-543. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 20959273 |
|---|---|
| DOI: | 10.1016/j.scib.2023.12.046 |
